Our Services

Diagnostic Imaging

Magnetic Resonance Imaging (MRI)

MRI uses radio waves and a strong magnetic field to produce clear and detailed pictures of the body, without the use of x-rays. It is a non-invasive way of viewing organs, soft tissues, bone and other internal body structures.

Computed Tomography (CT Scan)

A CT scan is an advanced X-ray technique that uses X-ray and computer technology to obtain cross-sectional images of the body, giving detailed information for diagnosis.


Ultrasound imaging (Sonography) is a method of obtaining real-time images from inside the human through the use of high frequency sound waves. No ionizing radiation (X-rays) or injections are used in ultrasound imaging which makes this modality an extremely safe and painless diagnostic tool.

Women & Fetal Imaging

At RadLink, Women & Fetal Imaging, we offer ultrasound scanning including 3D/4D scans by Fetal Medicine Foundation (UK) certified consultants and sonographers.


Mammography is a special imaging of the breasts using a low-dose X-ray system. It is used to aid in the diagnosis of breast diseases in women. Together with physical breast examination, it has proven to be the safest and most effective method to screen for early breast cancer.

Bone Mineral Densitometry (BMD)

BMD is the method used to quantify the mass of bone in the body. It is also effective in tracking the effects of treatment for osteoporosis and other conditions that cause bone loss.

X-ray (Digital)

X-ray is a conventional technique used for the visualization of the bones and soft tissue structures in the body. It employs the use of an X-ray beam and a receptor. The X-ray beam is passed through the patient’s anatomy of interest and a “negative” image is created on the film.

Nuclear Medicine

Molecular Imaging

Metabolic imaging using F-18 Fluorodeoxyglucose (FDG) and PET/CT has become the cornerstone of oncologic imaging and has been shown to be useful in tumor staging and follow-up. FDG PET/CT has also proven useful in predicting prognosis and treatment response.

• C-11 Acetate PET/CT
A combination of PET examinations with FDG and 11C-Acetate is shown to have an incremental value when compared to single tracer-imaging in the diagnosis for liver cancer.

• F-18 Choline PET/CT
F18-Fluoromethylcholine (FCH) has proven to be superior to FDG in the detection of metastatic disease, including that of extensive bone metastases from prostate cancer.

• Gallium-68 PSMA PET/CT
PET Imaging with 68Ga-PSMA can present lesions suspicious for prostate cancer with excellent contrast and a high detection rate even when the level of prostate specific antigen is low. It allows the identification of benign and malignant prostatic epithelium and may be a potentially valuable marker in the treatment of patients with prostate cancer.

PET imaging using Gallium-68 (Ga-68) labeled compound -DOTATATE offers higher resolution and improved pharmacokinetics compared with somatostatin receptor scintigraphy, with promising results in the detection of SST receptor-expressing tumors.

• NaF-18 PET/CT
Sodium Fluoride PET/CT bone scan has greater sensitivity and specificity than other nuclear medicine techniques. The higher photon flux with NaF-18 compared to traditional bone scanning agents makes the lesions more conspicuous and easier to see. This translates to detection of relatively higher number of lesions on PET bone scan.

Radionuclide Therapy

Xofigo is the therapeutic alpha particle-emitting pharmaceutical that is indicated for the treatment of castration-resistant prostate cancer (CRPC) patients with symptomatic bone metastases and no known visceral metastatic disease.